Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Hormonal Contraception · 1 trial · 2 indications
| Arm | Type | Description |
|---|---|---|
| Copper T Intrauterine Contraceptive Device | EXPERIMENTAL | - |
| Hormonal Contraception | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| Copper T Intrauterine Contraceptive Device | DEVICE | - |
| Hormonal Contraception | DRUG | - |
Inclusion Criteria: * desire for at least 2 years of continuous contraception * two or fewer sexual partners in the prior year Exclusion Criteria: * advanced HIV disease (WHO Stage III or IV) * history of a bleeding disorder * history of PID within the prior five years * less than 16 years of age...
Hormonal Contraception is used for pregnancy prevention. It is being studied in a Phase 3 clinical trial in HIV-infected women in Zambia, where it is compared with an intrauterine device (IUD) for contraceptive efficacy. The trial enrolled 600 female participants aged 16 years and older.
Hormonal Contraception is being developed by United Therapeutics Corporation, a company traded on the NASDAQ under the ticker symbol UTHR. The company is conducting a Phase 3 clinical trial of this small molecule contraceptive in HIV-infected women.
Hormonal Contraception is in Phase 3 clinical development. It is an investigational drug and has not been approved by the FDA. The Phase 3 trial, NCT00336245, has been completed and enrolled 600 participants.
Hormonal Contraception is associated with one completed Phase 3 clinical trial, NCT00336245, titled 'A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia.' The trial was active-controlled, randomized, and enrolled 600 female participants with HIV infection.
No, Hormonal Contraception is not the same as an IUD. In the clinical trial NCT00336245, hormonal contraception is compared against an intrauterine device (IUD) as an active control. The two are different contraceptive methods being evaluated for their effectiveness in preventing pregnancy.